Status:
TERMINATED
Additional Effect of Intrapulmonary Percussive Ventilation (IPV) on Respiration in People With Multiple Sclerosis (MS).
Lead Sponsor:
National Multiple Sclerosis Center
Collaborating Sponsors:
National MS Center Melsbroek
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to investigate whether intrapulmonary percussive ventilation (IPV) in combination with active breathing exercises using the flow-based incentive spirometer (Inspirix) has a positive ef...
Detailed Description
The primary research question includes "what is the additional effect of intensive IPV treatment in combination with active breathing exercises on respiratory power (Peak Expiratory Flow, PEF) in peop...
Eligibility Criteria
Inclusion
- diagnosis MS
- inpatient in the National Multiple Sclerosis Center Melsbroek for at least 3 weeks in the period Jan-Dec 2020
- adequate lip closure
- adequate cognitive functioning (MMSE\>26/30 \& clinical observation)
- Peak Expiratory Flow (PEF) with a cut off score of 80% or lower
Exclusion
- IPV or other breathing treatment of more than 1x/week within 3 months prior to study participation
- MS relapse within 3 months prior to study participation
- asthma or Chronic Obstructive Pulmonary Disease (COPD)
- infection of lower respiratory tract within 6 weeks prior to study participation
- infection of upper respiratory tract within 2 weeks prior to study participation
Key Trial Info
Start Date :
January 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 20 2020
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT04295616
Start Date
January 13 2020
End Date
July 20 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National MS Center
Melsbroek, Belgium, 1820